Abstract Submissions

Present Your Research at the 2026 NORD Breakthrough Summit

Academics, researchers, industry, government agencies, healthcare professionals, patient organizations and students that have conducted rare disease or orphan product research studies or public health projects relevant in rare disease are invited to submit an abstract for inclusion in the 2026 NORD Breakthrough Summit Poster Hall.

Key Dates:
Submission deadline: July 22, 2026
NORD notifies authors of acceptance: August 24, 2026

See Abstract Submission Guidelines here.

Prior to submitting your abstract, please read our abstract guidelines carefully. Submitted abstracts that do not comply with the guidelines and format will not be reviewed or considered for inclusion in the poster hall.


Questions: Please email [email protected]

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Main Point of Contact

All correspondence with NORD, including decision notification, will be through the main point of contact unless noted below.
Main Point of Contact Name*

Abstract Author Details

* indicates required field

Presenting Author

This individual is anyone that is an author that can attend the NORD Breakthrough Summit and present the work by being available next to the poster during the networking breaks and the "Sip and Science" Poster Hall Reception.
Please see the agenda for times.
Please note that non-authors are not permitted to present the work.

This person can be relisted if they are not the first author.

Author's Name (Last) | Additional Author's Name (First Initial) | Additional Author’s Degrees/Credentials* | Additional Author's | Company/Organization Name* | Additional Author's Email*
One per line

Notifications

Please list the email address for each person other than the main point of contact who should receive notifications about this submission.

Attendance Details

Submission of an abstract constitutes a commitment by the presenting author to present their work in the poster hall if the abstract is accepted. All additional abstract authors are encouraged to purchase a registration to attend the Summit. 

Abstract Details

Abstract submissions are accepted in the areas of Innovative Research in Rare Diseases and Orphan Products, Medical Education Advancement in Rare Diseases and Orphan Products, Patient Engagement and Education and Other Topics.
The Word document should include title and abstract. Author names should not be included and entered above only.
Max. file size: 5 MB.

Figures and Tables

Upload up to 2 images / figures with title or caption. Uploads must be in jpg form.
Max. file size: 50 MB.
50 MB max
Max. file size: 50 MB.
50 MB max
Content Agreement*
Author(s) hereby represents and warrants that she/he/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work does not infringe upon any copyright, proprietary or personal right of any third party.

IMPORTANT

Prior to submitting your abstract, please read our abstract guidelines carefully. Submitted abstracts that do not comply with the guidelines and format will not be reviewed or considered for inclusion in the poster hall.

Questions: Please email [email protected]